| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/30/2013 | US8497270 Macrocyclic integrase inhibitors |
| 07/30/2013 | US8496940 Prevention and treatment of sub-clinical PCVD |
| 07/30/2013 | CA2790087C Viral inhibitor compositions for in vivo therapeutic use comprising a combination of (-)-carvone, (+)-carvone, geraniol and a further essential oil component |
| 07/30/2013 | CA2691091C Fusion protein, macromolecule assembled from the fusion protein, and its use in the prevention or treatment of human papillomavirus related diseases |
| 07/30/2013 | CA2651634C Substituted piperidino phenyloxazolidinones |
| 07/30/2013 | CA2645058C Pharmaceutical composition for external use |
| 07/30/2013 | CA2575472C Hiv inhibiting 5-substituted pyrimidines |
| 07/30/2013 | CA2569530C Thienopyrazole derivative having pde 7 inhibitory activity |
| 07/30/2013 | CA2563400C Medicament for the treatment of fungal infections, particularly aspergillosis |
| 07/30/2013 | CA2483917C Formulations limiting spread of pulmonary infections |
| 07/30/2013 | CA2480284C Bioactive hexane fraction from vetiveria zizanioides |
| 07/30/2013 | CA2462886C Flashmelt oral dosage formulation |
| 07/25/2013 | WO2013109675A2 Compositions and methods for treating cancer and inflammation-related diseases and conditions |
| 07/25/2013 | WO2013109201A1 Pharmaceutical compositions comprising cefprozil and clavulanic acid |
| 07/25/2013 | WO2013108193A1 Synthetic peptides for treatment of bacterial infections |
| 07/25/2013 | WO2013108105A2 Novel solvates of darunavir |
| 07/25/2013 | WO2013107988A1 Method for formulating a vaccine containing at least two antigens capable of adsorbing onto aluminium oxyhydroxide |
| 07/25/2013 | WO2013107609A1 Systemic administration forms with controlled release and improved stability |
| 07/25/2013 | WO2013107515A1 Eye drop composition |
| 07/25/2013 | WO2013107388A1 Interferon and immune globulin fc section fusion protein |
| 07/25/2013 | WO2013107290A1 A novel paramyxovirus and uses thereof |
| 07/25/2013 | WO2013106937A1 3' equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-virals |
| 07/25/2013 | WO2013081448A3 Compositions for controlling ganoderma disease in plants and method thereof by using endophytic fungus, hendersonia ganoef1 |
| 07/25/2013 | WO2013042140A4 Non antibiotic, non peptide compounds for antibiotic efficacy & safety enhancement |
| 07/25/2013 | WO2013040492A3 Methods for treating hcv |
| 07/25/2013 | WO2013030778A3 Organic compositions to treat hsf1-related diseases |
| 07/25/2013 | US20130190839 Drug delivery using a sacrificial host |
| 07/25/2013 | US20130190250 Polynucleotides Encoding Human Signal Peptide-Containing Proteins |
| 07/25/2013 | US20130190247 Peptide antagonists of zonulin and methods for use of the same |
| 07/25/2013 | US20130189346 Wound dressing |
| 07/25/2013 | US20130189338 Bone fibers having extended length |
| 07/25/2013 | US20130189306 Flavivirus Vaccines |
| 07/25/2013 | US20130189296 COMPOSITION FOR USE IN INHIBITING OR KILLING Phrphyromonas gingivalis AND USE IN APPLICATIONS FOR ALLEVIATING OR TREATING PERIDONTAL DISEASE AND RELATED DISEASES |
| 07/25/2013 | US20130189294 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 07/25/2013 | US20130189219 N-terminally chemically modified protein compositions and methods |
| 07/25/2013 | DE112011102638T5 Pharmazeutische Zusammensetzung und Verfahren zur Behandlung und Prävention der Krankheiten, die durch HIV verursacht werden oder mit HIV zusammenhängen Related pharmaceutical composition and method for the treatment and prevention of diseases caused by HIV or HIV |
| 07/25/2013 | CA2863500A1 Eye drop composition |
| 07/24/2013 | EP2617709A1 Guanidine derivatives as antiviral agents |
| 07/24/2013 | EP2617426A1 Inhibitor of hmgb protein-mediated immune response activation, and screening method |
| 07/24/2013 | EP2616478A2 Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo |
| 07/24/2013 | EP2616474A1 Novel antiviral acyclic nucleoside phosphonates |
| 07/24/2013 | EP2616461A2 Potent and selective inhibitors of hepatitis c virus |
| 07/24/2013 | EP2616456A1 Nuclear export inhibitors |
| 07/24/2013 | EP2616099A1 Immunogenic compositions |
| 07/24/2013 | EP2616080A1 2' -fluoro substituted carba-nucleoside analogs for antiviral treatment |
| 07/24/2013 | EP2616065A1 Glyco-substituted dihydroxy-chlorins and b-functionalized chlorins for anti-microbial photodynamic therapy |
| 07/24/2013 | EP2616062A1 Use of derivatives of pentaphyrine as antimicrobial and desinfectant agents |
| 07/24/2013 | EP2616059A2 Pharmaceutical and nutraceutical compositions of abscisic acid |
| 07/24/2013 | EP2616052A1 Methods, compounds and compositions relating to activating a latent virus |
| 07/24/2013 | CN1989122B Novel cylopenta[b]benzofuran derivatives and the utilization thereof |
| 07/24/2013 | CN103221399A 2-piperazin-1-l-4h-1,3-benzothiazin-4-one derivatives and their use for the treatment of mammalian infections |
| 07/24/2013 | CN103221065A Hiv疫苗 Hiv Vaccine |
| 07/24/2013 | CN103221064A Immune methods against influenza viruses and combinatorial vaccines thereof |
| 07/24/2013 | CN103221054A Novel polymer derivative of cytidine metabolism antagonist |
| 07/24/2013 | CN103221053A New treatments of hepatitis c virus infection |
| 07/24/2013 | CN103215345A Host relative gene for inhibiting replication of influenza virus, screening method and application |
| 07/24/2013 | CN103215302A Method for generating HPV18 L1 protein by using hansenula polymorpha expression system |
| 07/24/2013 | CN103215298A Recombinant expression vector for preparing anti-CSFV (Classical Swine Fever Virus) transgenic lactobacillus preparation |
| 07/24/2013 | CN103215269A Dsrna for treating viral infection |
| 07/24/2013 | CN103215267A siRNA for inhibiting influenza virus-related gene and application |
| 07/24/2013 | CN103215207A Pseudomonas strain applicable to oil accumulation environment and application thereof |
| 07/24/2013 | CN103215133A Callicarpa kwangtungensis chun. essential oil extract, its preparation method, pharmaceutical composition containing Callicarpa kwangtungensis chun. essential oil extract and application |
| 07/24/2013 | CN103214582A Immunogenic fusion protein for tuberculosis and application of immunogenic fusion protein |
| 07/24/2013 | CN103214579A Animal fusion recombinant interferon |
| 07/24/2013 | CN103214570A Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or Nl-subtype and uses thereof |
| 07/24/2013 | CN103214569A Site-directed modification of fviii |
| 07/24/2013 | CN103214560A Polypeptide used for preparing bovine foot and mouth disease type O peptide vaccine, and preparation method and application thereof |
| 07/24/2013 | CN103214558A Antimicrobial polypeptides |
| 07/24/2013 | CN103214547A Compound and an application in preparation of antibiosis medicament |
| 07/24/2013 | CN103214484A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 07/24/2013 | CN103214483A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 07/24/2013 | CN103214464A Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists |
| 07/24/2013 | CN103214457A Azole antifungal compound, its preparation method and application |
| 07/24/2013 | CN103214429A 1-substituted phenyl-3-(N-phenothiazinyl)propyl-2-ene-1-ketone as well as preparation method and application thereof |
| 07/24/2013 | CN103214409A Synthesis of tetracyclines and analogues thereof |
| 07/24/2013 | CN103212089A Preparation method and application of carbon nanomaterial-immunostimulatory sequence compound |
| 07/24/2013 | CN103212087A Antibiotic-chitosan covalent conjugate and preparation method and application thereof in preparation of anti-tumor medicines |
| 07/24/2013 | CN103212076A Compositions comprising ceftaroline and methods of treatment |
| 07/24/2013 | CN103212068A Preparation method of chicken infectious bronchitis N-2-hydroxypropyl trimethyl ammonium chloride chitosan/carboxymethyl chitosan nano living vaccine |
| 07/24/2013 | CN103212067A Porcine contagious pleuropneumonia trivalent inactivated vaccine and its preparation method |
| 07/24/2013 | CN103212060A Application of protein and composition thereof in preparation of product used for preventing, diagnosing or treating EHEC (Enterohemorrhagic Escherichia Coli) infection |
| 07/24/2013 | CN103212059A Composition containing antifungal drug and lactate buffering liquid |
| 07/24/2013 | CN103212058A Composition containing antifungal drug and lactate buffering agent |
| 07/24/2013 | CN103212034A Chinese medicinal composition for treating chronic viral hepatitis |
| 07/24/2013 | CN103212033A Drug composition for treating viral hepatitis |
| 07/24/2013 | CN103212025A Traditional Chinese medicine preparation for treating postherpetic neuralgia |
| 07/24/2013 | CN103212015A Pharmaceutical composition for preventing avian influenza and preparation method thereof |
| 07/24/2013 | CN103211997A Antibacterial and antiviral traditional Chinese medicine composition and preparation method thereof |
| 07/24/2013 | CN103211993A Traditional Chinese medicine composition for treating porcine transmissible gastroenteritis |
| 07/24/2013 | CN103211991A Chinese medicinal composition treating pneumonia |
| 07/24/2013 | CN103211989A Chinese medicine composition for preventing and treating bird flu and preparation method of Chinese medicine composition |
| 07/24/2013 | CN103211988A Pharmaceutical composition for treating porcine infectious gastrointestinal inflammations |
| 07/24/2013 | CN103211985A Traditional Chinese medicine for treating infectious serositis of duck |
| 07/24/2013 | CN103211942A Chinese medicament for treating acute conjunctivitis |
| 07/24/2013 | CN103211923A Formula of Chinese herbal medicine health mask |
| 07/24/2013 | CN103211922A Antiviral and anti-bird flu drug and preparation method thereof |
| 07/24/2013 | CN103211920A Callicarpa kwangtungensis chun. low-polarity ingredient extract, pharmaceutical composition containing Callicarpa kwangtungensis chun. low-polarity ingredient extract, preparation method and application |
| 07/24/2013 | CN103211910A Detoxifying and lipid reducing capsules and preparation method thereof |
| 07/24/2013 | CN103211909A Traditional Chinese medicine composition for treating dandruff |
| 07/24/2013 | CN103211906A Medicinal food used for viral diarrhea |